Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products
Use oral b12 to avoid additional injections
The details are proprietary, Sikiric said, and he declined to share them
However, the brain endogenous antioxidant defenses have not been enough to your demand
Zitouni K, Nourooz-Zadeh J, Harry D, Kerry SM, Betteridge DJ, Cappuccio FP, et al
Research shows that low dose semaglutide for maintenance can be equally effective as higher doses for maintaining body composition, emphasizing the significance of establishing the ideal balance suited to your needs